ZELMUNIS Trademark

Trademark Overview

On Wednesday, April 29, 2015, a trademark application was filed for ZELMUNIS with the United States Patent and Trademark Office. The USPTO has given the ZELMUNIS trademark a serial number of 79169814. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 16, 2022. This trademark is owned by UCB PHARMA S.A.. The ZELMUNIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and substances, namely, medicines and pharmaceutical preparations for the treatment of central nervous system diseases and for the treatment of immune system diseases
zelmunis

General Information

Serial Number79169814
Word MarkZELMUNIS
Filing DateWednesday, April 29, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 16, 2022
Registration Number4906795
Registration DateTuesday, March 1, 2016
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 15, 2015

Trademark Statements

Goods and ServicesPharmaceutical products and substances, namely, medicines and pharmaceutical preparations for the treatment of central nervous system diseases and for the treatment of immune system diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUCB PHARMA S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBE
Party NameUCB PHARMA S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE
Party NameUCB PHARMA S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events

Event DateEvent Description
Monday, July 10, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, June 20, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, June 20, 2023INVALIDATION PROCESSED
Tuesday, May 16, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 16, 2022CANCELLED SECTION 71
Monday, March 1, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 5, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 24, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, June 6, 2016FINAL DISPOSITION NOTICE SENT TO IB
Monday, June 6, 2016FINAL DISPOSITION PROCESSED
Wednesday, June 1, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 1, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, December 15, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2015PUBLISHED FOR OPPOSITION
Wednesday, November 25, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 12, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 9, 2015ASSIGNED TO LIE
Wednesday, September 30, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 11, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 10, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 10, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 10, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, August 29, 2015REFUSAL PROCESSED BY IB
Thursday, August 13, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 13, 2015REFUSAL PROCESSED BY MPU
Thursday, August 13, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 12, 2015NON-FINAL ACTION WRITTEN
Tuesday, August 11, 2015APPLICATION FILING RECEIPT MAILED
Monday, August 10, 2015ASSIGNED TO EXAMINER
Thursday, August 6, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 3, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 30, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

zelmunis treatment pharmaceutical system diseases immune nervous central preparations products substances